Genus (LON:GNS) Earns Buy Rating from Shore Capital

Genus (LON:GNS)‘s stock had its “buy” rating reissued by analysts at Shore Capital in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports.

Genus Stock Performance

Genus has a 12 month low of GBX 1,478 ($18.73) and a 12 month high of GBX 2,378 ($30.14). The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.54. The firm has a 50 day moving average price of GBX 1,900.42 and a 200 day moving average price of GBX 1,821.29. The stock has a market capitalization of £1.08 billion, a P/E ratio of 13,700.00, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37.

Insider Activity at Genus

In other Genus news, insider Jorgen Kokke sold 2,186 shares of the stock in a transaction on Monday, September 16th. The stock was sold at an average price of GBX 1,956 ($24.79), for a total transaction of £42,758.16 ($54,199.72). 0.75% of the stock is owned by company insiders.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.